These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17868161)

  • 1. Virtual screening for selective allosteric mGluR1 antagonists and structure-activity relationship investigations for coumarine derivatives.
    Noeske T; Jirgensons A; Starchenkovs I; Renner S; Jaunzeme I; Trifanova D; Hechenberger M; Bauer T; Kauss V; Parsons CG; Schneider G; Weil T
    ChemMedChem; 2007 Dec; 2(12):1763-73. PubMed ID: 17868161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.
    Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T
    Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
    Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
    J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative modulation of group I metabotropic glutamate receptors.
    Vanejevs M; Jatzke C; Renner S; Müller S; Hechenberger M; Bauer T; Klochkova A; Pyatkin I; Kazyulkin D; Aksenova E; Shulepin S; Timonina O; Haasis A; Gutcaits A; Parsons CG; Kauss V; Weil T
    J Med Chem; 2008 Feb; 51(3):634-47. PubMed ID: 18173231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1.
    Kohara A; Toya T; Tamura S; Watabiki T; Nagakura Y; Shitaka Y; Hayashibe S; Kawabata S; Okada M
    J Pharmacol Exp Ther; 2005 Oct; 315(1):163-9. PubMed ID: 15976016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one.
    Satow A; Suzuki G; Maehara S; Hikichi H; Murai T; Murai T; Kawagoe-Takaki H; Hata M; Ito S; Ozaki S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2009 Jul; 330(1):179-90. PubMed ID: 19359526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
    Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
    Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists.
    Mantell SJ; Gibson KR; Osborne SA; Maw GN; Rees H; Dodd PG; Greener B; Harbottle GW; Million WA; Poinsard C; England S; Carnell P; Betts AM; Monhemius R; Prime RL
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2190-4. PubMed ID: 19289283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
    O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
    Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists.
    Costantino G; Pellicciari R
    J Med Chem; 1996 Sep; 39(20):3998-4006. PubMed ID: 8831765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activity.
    Alagille D; Baldwin RM; Roth BL; Wroblewski JT; Grajkowska E; Tamagnan GD
    Bioorg Med Chem; 2005 Jan; 13(1):197-209. PubMed ID: 15582465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
    Suzuki G; Tsukamoto N; Fushiki H; Kawagishi A; Nakamura M; Kurihara H; Mitsuya M; Ohkubo M; Ohta H
    J Pharmacol Exp Ther; 2007 Oct; 323(1):147-56. PubMed ID: 17609420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs.
    Jiang L; Zhang X; Chen X; He Y; Qiao L; Zhang Y; Li G; Xiang Y
    Molecules; 2015 Jul; 20(7):12769-86. PubMed ID: 26184151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel mGluR1 antagonists: a multistep virtual screening approach based on an SVM model and a pharmacophore hypothesis significantly increases the hit rate and enrichment factor.
    Li GB; Yang LL; Feng S; Zhou JP; Huang Q; Xie HZ; Li LL; Yang SY
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1736-40. PubMed ID: 21316965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
    Chen Y; Goudet C; Pin JP; Conn PJ
    Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
    Nakamura M; Kurihara H; Suzuki G; Mitsuya M; Ohkubo M; Ohta H
    Bioorg Med Chem Lett; 2010 Jan; 20(2):726-9. PubMed ID: 20005101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity.
    Cosford ND; Tehrani L; Roppe J; Schweiger E; Smith ND; Anderson J; Bristow L; Brodkin J; Jiang X; McDonald I; Rao S; Washburn M; Varney MA
    J Med Chem; 2003 Jan; 46(2):204-6. PubMed ID: 12519057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Alkylated homoibotenic acid (HIBO) analogues: versatile pharmacological agents with diverse selectivity profiles towards metabotropic and ionotropic glutamate receptor subtypes.
    Madsen U; Pickering DS; Nielsen B; Bräuner-Osborne H
    Neuropharmacology; 2005; 49 Suppl 1():114-9. PubMed ID: 15996690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.